Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Diggelmann S"'
Autor:
Eckmann J; Roche Innovation Center Munich, Germany., Fauti T; Roche Innovation Center Zurich, Switzerland., Biehl M; Roche Innovation Center Zurich, Switzerland., Zabaleta A; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicadas (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain., Blanco L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain., Lelios I; Roche Innovation Center Basel, Switzerland., Gottwald S; Roche Innovation Center Munich, Germany., Rae R; Roche Innovation Center Munich, Germany., Lechner S; Roche Innovation Center Munich, Germany., Bayer C; Roche Innovation Center Munich, Germany., Dekempe Q; Roche Innovation Center Munich, Germany., Osl F; Roche Innovation Center Munich, Germany., Carrié N; centre de recherche en cancérologie de toulouse INSERM U1037, toulouse, France., Kassem S; Centre de rechecrche en cancérologie de Toulouse de Inserm U1037, Toulouse, France., Lorenz S; Roche Innovation Center Munich, Germany., Christopeit T; Roche Innovation Center Munich, Germany., Carpy A; Roche Innovation Center Munich, Germany., Bujotzek A; Roche Innovation Center Munich, Germany., Bröske AE; Roche Innovation Center Munich, Germany., Dekhtiarenko I; Roche Innovation Center Zurich, Switzerland., Attig J; Pharmaceutical Sciences, pRED, Switzerland., Kunz L; Roche Innovation Center Zurich, Switzerland., Cremasco F; Roche Innovation Center Zurich, Switzerland., Adelfio R; Roche Innovation Center Zurich, Switzerland., Fertig G; Roche Innovation Center Munich, Germany., Dengl S; Roche Innovation Center Munich, Germany., Gassner C; Roche Innovation Center Munich, Germany., Bormann F; Roche Innovation Center Munich, Germany., Kirstenpfad C; Roche Innovation Center Munich, Germany., Kraft TE; Pharmaceutical Sciences, pRED, Germany., Diggelmann S; Roche Innovation Center Zurich, Switzerland., Knobloch M; Roche Innovation Center Munich, Switzerland., Hage C; Roche Innovation Center Munich, Germany., Feddersen R; Roche Innovation Center Munich, Germany., Heidkamp G; Roche Innovation Center Munich, Germany., Pöschinger T; Roche Innovation Center Munich, Germany., Mayoux ML; University of Zurich, Zurich, Switzerland., Bernasconi L; Lonza, Basel, Switzerland., Dumontet C; Hospices Civils de Lyon, Lyon, France., Prosper F; Clinica Universidad de Navarra, Pamplona, Spain., Martinet L; CRCT, Toulouse, France., Leclair S; Roche Innovation Center Munich, Germany., Xu W; METiS Pharmaceuticals, Hangzhou, China., Paiva B; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC (CB16/12/00369), Pamplona, Spain., Klein C; Roche Innovation Center Zurich, Switzerland., Umaña P; Roche Innovation Center Zurich, Switzerland.
Publikováno v:
Blood [Blood] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.
Autor:
Van De Vyver AJ; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland. arthur.van_de_vyver@roche.com.; Saarland University, Department of Clinical Pharmacy, Saarbrücken, Germany., Weinzierl T; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Eigenmann MJ; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Frances N; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Herter S; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Buser RB; Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center, Zürich, Switzerland., Somandin J; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Diggelmann S; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Limani F; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Lehr T; Saarland University, Department of Clinical Pharmacy, Saarbrücken, Germany., Bacac M; Roche Pharma Research and Early Development, Cancer Immunotherapy Department 2, Roche Innovation Center, Zürich, Switzerland., Walz AC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Feb; Vol. 20 (2), pp. 357-366. Date of Electronic Publication: 2020 Dec 09.
Autor:
Claus C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Ferrara C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Xu W; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Sam J; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Lang S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Uhlenbrock F; University of Basel, Department of Biomedicine, Hebelstrasse 20, 4031 Basel, Switzerland., Albrecht R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Herter S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Schlenker R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Hüsser T; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Diggelmann S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Challier J; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Mössner E; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Hosse RJ; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Hofer T; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Brünker P; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Joseph C; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Benz J; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Ringler P; University of Basel, Center for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, Klingelbergstrasse 70, 4056 Basel, Switzerland., Stahlberg H; University of Basel, Center for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, Klingelbergstrasse 70, 4056 Basel, Switzerland., Lauer M; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Perro M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Chen S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Küttel C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Bhavani Mohan PL; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Nicolini V; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Birk MC; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Ongaro A; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Prince C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Gianotti R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Dugan G; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Whitlow CT; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Solingapuram Sai KK; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Caudell DL; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Burgos-Rodriguez AG; Caribbean Primate Research Center, PO Box 1053, Sabana Seca, Puerto Rico 00952, USA., Cline JM; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Hettich M; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Ceppi M; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Giusti AM; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Crameri F; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Driessen W; Roche Innovation Center Basel, pRED, Grenzacherstrasse 124, 4070 Basel, Switzerland., Morcos PN; Roche Innovation Center New York, pRED, 430 E 29th St, New York, NY 10016, USA., Freimoser-Grundschober A; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Levitsky V; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Amann M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Grau-Richards S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., von Hirschheydt T; Roche Innovation Center Munich, pRED, Nonnenwald 2, 82377 Penzberg, Germany., Tournaviti S; Roche Innovation Center Munich, pRED, Nonnenwald 2, 82377 Penzberg, Germany., Mølhøj M; Roche Innovation Center Munich, pRED, Nonnenwald 2, 82377 Penzberg, Germany., Fauti T; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Heinzelmann-Schwarz V; University Hospital Basel, Gynecological Oncology, Spitalstrasse 21, 4031 Basel, Switzerland., Teichgräber V; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Colombetti S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Bacac M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Zippelius A; University of Basel, Department of Biomedicine, Hebelstrasse 20, 4031 Basel, Switzerland., Klein C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland., Umaña P; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland. pablo.umana@roche.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2019 Jun 12; Vol. 11 (496).
Autor:
Bacac M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland. marina.bacac@roche.com pablo.umana@roche.com., Colombetti S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Herter S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Sam J; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Perro M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Chen S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Bianchi R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Richard M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Schoenle A; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Nicolini V; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Diggelmann S; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Limani F; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Schlenker R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Hüsser T; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Richter W; Roche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, pRED, Basel, Switzerland., Bray-French K; Roche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, pRED, Basel, Switzerland., Hinton H; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Giusti AM; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Freimoser-Grundschober A; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Lariviere L; Roche Innovation Center Munich, Roche Pharmaceutical Research and Early Development, pRED, Munich, Germany., Neumann C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Klein C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland., Umaña P; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, pRED, Zurich, Switzerland. marina.bacac@roche.com pablo.umana@roche.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Oct 01; Vol. 24 (19), pp. 4785-4797. Date of Electronic Publication: 2018 May 01.
Autor:
Caspers P; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland patrick.caspers@actelion.com., Locher HH; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland., Pfaff P; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland., Diggelmann S; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland., Rueedi G; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland., Bur D; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland., Ritz D; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Jul 25; Vol. 61 (8). Date of Electronic Publication: 2017 Jul 25 (Print Publication: 2017).
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.
Autor:
Liu, Xinyuan1 (AUTHOR), Zhao, Juanjuan2 (AUTHOR), Guo, Xiangqian1 (AUTHOR), Song, Yongping2 (AUTHOR) songyp@zzu.edu.cn
Publikováno v:
Journal of Hematology & Oncology. 8/3/2023, Vol. 16 Issue 1, p1-4. 4p.
Autor:
Ellis‐Davies, Graham C. R.1 (AUTHOR) graham.davies@mssm.edu
Publikováno v:
Angewandte Chemie. 2/20/2023, Vol. 135 Issue 9, p1-12. 12p.
Autor:
Yu, Meng, Tang, Xiaohui, Li, Zhenhua, Wang, Weidong, Wang, Shaopeng, Li, Min, Yu, Qiuliyang, Xie, Sijia, Zuo, Xiaolei, Chen, Chang
Publikováno v:
Chemical Society Reviews; 5/7/2024, Vol. 53 Issue 9, p4463-4489, 27p
Autor:
Gayen S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India., Mukherjee S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India., Dasgupta S; Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, West Bengal, 741249, India., Roy S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India. souvikroy35@gmail.com.
Publikováno v:
Apoptosis : an international journal on programmed cell death [Apoptosis] 2024 Dec; Vol. 29 (11-12), pp. 1879-1913. Date of Electronic Publication: 2024 Oct 01.
Autor:
Schaudy, Erika1 (AUTHOR), Somoza, Mark M.1,2,3 (AUTHOR) mark.somoza@univie.ac.at, Lietard, Jory1 (AUTHOR) jory.lietard@univie.ac.at
Publikováno v:
Chemistry - A European Journal. 11/11/2020, Vol. 26 Issue 63, p14310-14314. 5p.